210 related articles for article (PubMed ID: 27720823)
1. Higher prevalence of cancer related mutations 1762T/1764A and PreS deletions in hepatitis B virus (HBV) isolated from HBV/HIV co-infected compared to HBV-mono-infected Chinese adults.
Li KW; Kramvis A; Liang S; He X; Chen QY; Wang C; Yang QL; Hu LP; Jia HH; Fang ZL
Virus Res; 2017 Jan; 227():88-95. PubMed ID: 27720823
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of hepatitis B virus isolated from Black South African cancer patients, with and without hepatocellular carcinoma.
Mak D; Kramvis A
Arch Virol; 2020 Aug; 165(8):1815-1825. PubMed ID: 32504396
[TBL] [Abstract][Full Text] [Related]
3. Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland.
Grabarczyk P; Garmiri P; Liszewski G; Doucet D; Sulkowska E; Brojer E; Allain JP;
J Viral Hepat; 2010 Jun; 17(6):444-52. PubMed ID: 19780948
[TBL] [Abstract][Full Text] [Related]
4. Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa.
Makondo E; Bell TG; Kramvis A
PLoS One; 2012; 7(9):e46345. PubMed ID: 23029487
[TBL] [Abstract][Full Text] [Related]
5. A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma.
Liu S; Xie J; Yin J; Zhang H; Zhang Q; Pu R; Li C; Ni W; Wang H; Cao G
J Med Virol; 2011 Jan; 83(1):45-53. PubMed ID: 21108338
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
[TBL] [Abstract][Full Text] [Related]
7. The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infection.
Eschlimann M; Malvé B; Velay A; Fenaux H; Berger S; Frippiat JP; Zoulim F; Bensenane M; Bronowicki JP; Goehringer F; May T; Jeulin H; Schvoerer E
J Clin Virol; 2017 Sep; 94():115-122. PubMed ID: 28822954
[TBL] [Abstract][Full Text] [Related]
8. Profiles of mutations in hepatitis B virus surface and polymerase genes isolated from treatment-naïve Nigerians infected with genotype E.
Olusola BA; Faneye AO; Oluwasemowo OO; Motayo BO; Adebayo S; Oludiran-Ayoade AE; Aleru B; George UE; Oragwa AO
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33704041
[No Abstract] [Full Text] [Related]
9. Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan.
Yousif M; Mudawi H; Hussein W; Mukhtar M; Nemeri O; Glebe D; Kramvis A
Int J Infect Dis; 2014 Dec; 29():125-32. PubMed ID: 25449246
[TBL] [Abstract][Full Text] [Related]
10. Evolution of HBV S-gene in the backdrop of HDV co-infection.
Baig S; Abidi SH; Azam Z; Majid S; Khan S; Khanani MR; Ali S
J Med Virol; 2018 Aug; 90(8):1328-1336. PubMed ID: 29663447
[TBL] [Abstract][Full Text] [Related]
11. Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon.
Bivigou-Mboumba B; François-Souquière S; Deleplancque L; Sica J; Mouinga-Ondémé A; Amougou-Atsama M; Chaix ML; Njouom R; Rouet F
PLoS One; 2016; 11(1):e0143869. PubMed ID: 26764909
[TBL] [Abstract][Full Text] [Related]
12. Characterization of hepatitis B virus mutations in untreated patients co-infected with HIV and HBV based on complete genome sequencing.
Tangkijvanich P; Sa-Nguanmoo P; Avihingsanon A; Ruxrungtham K; Poovorawan K; Poovorawan Y
J Med Virol; 2013 Jan; 85(1):16-25. PubMed ID: 23024025
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China.
Huang SM; Cai WP; Hu FY; Lan Y; Liao BL; Chen YP; Tang XP
Int J STD AIDS; 2016 Sep; 27(10):890-7. PubMed ID: 26384940
[TBL] [Abstract][Full Text] [Related]
14. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study.
Yin J; Zhang H; He Y; Xie J; Liu S; Chang W; Tan X; Gu C; Lu W; Wang H; Bi S; Cui F; Liang X; Schaefer S; Cao G
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):777-86. PubMed ID: 20160279
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection.
Pourkarim MR; Lemey P; Amini-Bavil-Olyaee S; Houspie L; Verbeeck J; Rahman M; Maes P; Vanwijngaerden E; Nevens F; Van Ranst M
J Med Virol; 2011 Nov; 83(11):1876-84. PubMed ID: 21915860
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of hepatitis B virus genotype C/C1 in the Minangkabau ethnic group in Indonesia.
Siburian MD; Utama A; Dhenni R; Arnelis N; Fanany I; Intan MD; Kurniasih TS; Andriani F; Afadlal S; Julianto EB; Rasman WS; Zubir N; Mathew G
Virol J; 2013 Jan; 10():27. PubMed ID: 23336976
[TBL] [Abstract][Full Text] [Related]
17. Identification of mutations in the S gene of hepatitis B virus in HIV positive Mexican patients with occult hepatitis B virus infection.
Enriquez-Navarro K; Maldonado-Rodriguez A; Rojas-Montes O; Torres-Ibarra R; Bucio-Ortiz L; De la Cruz MA; Torres-Flores J; Xoconostle-Cazares B; Lira R
Ann Hepatol; 2020; 19(5):507-515. PubMed ID: 32592870
[TBL] [Abstract][Full Text] [Related]
18. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
Chen BF
World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298
[TBL] [Abstract][Full Text] [Related]
19. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan.
Chen CH; Changchien CS; Lee CM; Tung WC; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
Int J Cancer; 2009 Aug; 125(3):621-9. PubMed ID: 19431214
[TBL] [Abstract][Full Text] [Related]
20. Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.
Li GJ; Harrison TJ; Yang JY; Chen QY; Wang XY; Fang ZL
Liver Int; 2013 Jul; 33(6):936-43. PubMed ID: 23517325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
